These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 845982)

  • 1. Determination of enantiomeric homogeneity (optical purity) of cyclophosphamide by nuclear magnetic resonance spectroscopy.
    Zon G; Brandt JA; Egan W
    J Natl Cancer Inst; 1977 Apr; 58(4):1117-9. PubMed ID: 845982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic resolutions. XIV. Optical resolution of the racemic anticancer drug ifosfamide and other chiral oxazaphosphorines.
    Blaschke G; Maibaum J
    J Chromatogr; 1986 Sep; 366():329-34. PubMed ID: 3782324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomeric purity determination of acetyl-L-carnitine by NMR with chiral lanthanide shift reagents.
    Kagawa M; Machida Y; Nishi H; Haginaka J
    J Pharm Biomed Anal; 2005 Aug; 38(5):918-23. PubMed ID: 16024206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of enantiomeric purity of nicotine in pharmaceutical preparations by 13C-NMR in the presence of a chiral lanthanide shift reagent.
    Jaroszewski JW; Olsson A
    J Pharm Biomed Anal; 1994 Mar; 12(3):295-9. PubMed ID: 8031927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the optical purity of timolol maleate by proton nuclear magnetic resonance spectroscopy with a chiral Pr(III) shift reagent.
    Hanna GM; Lau-Cam CA
    J Pharm Biomed Anal; 1995 Oct; 13(11):1313-9. PubMed ID: 8634348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of enantiomeric purity of tranylcypromine sulfate by proton magnetic resonance spectroscopy with chiral lanthanide shift reagent.
    Hanna GM; Lau-Cam CA
    J Assoc Off Anal Chem; 1989; 72(4):552-5. PubMed ID: 2759984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the optical purity and absolute configuration of threo-methylphenidate by proton nuclear magnetic resonance spectroscopy with chiral solvating agent.
    Hanna GM; Lau-Cam CA
    J Pharm Biomed Anal; 1993 Aug; 11(8):665-70. PubMed ID: 8257731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine.
    Salsbury JS; Isbester PK
    Magn Reson Chem; 2005 Nov; 43(11):910-7. PubMed ID: 16052604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical purity determination, conformer populations and 1H NMR spectral simplification with lanthanide shift reagents--part IX. A method for improved analytical precision for "DOEt", 2,5-dimethoxy-4-ethylamphetamine.
    Hatzis A; Rothchild R
    J Pharm Biomed Anal; 1987; 5(2):119-29. PubMed ID: 16867532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the enantiomeric composition of carprofen by proton nuclear magnetic resonance spectroscopy with a chiral lanthanide-shift reagent.
    Hanna GM; Lau-Cam CA
    Talanta; 1989 Sep; 36(9):883-7. PubMed ID: 18964827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical purity determination and (1)H-NMR spectral simplification with lanthanide shift reagents - VIII. An indacrinone precursor, 6,7-dichloro-5-methoxy-2-methyl-2-phenyl-1-indanone.
    Hatzis A; Rothchild R
    J Pharm Biomed Anal; 1986; 4(4):443-9. PubMed ID: 16867580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical purity determination of threo-methylphenidate hydrochloride using a chiral europium nuclear magnetic resonance (NMR) shift reagent.
    Hanna GM; Lau-Cam CA
    Pharm Res; 1990 Jul; 7(7):726-9. PubMed ID: 2395800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the optical purity of indacrinone by proton nuclear magnetic resonance spectroscopy using chiral lanthanide chelates.
    Hanna GM; Lau-Cam CA
    J Pharm Biomed Anal; 1989; 7(8):919-28. PubMed ID: 2562290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct enantiomeric purity determination of the chiral anesthetic drug bupivacaine by 1H NMR spectroscopy.
    Hanna GM
    Pharmazie; 2001 Apr; 56(4):314-7. PubMed ID: 11338671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific synthesis of chiral metabolites of ifosfamide and their determination in the urine.
    Misiura K; Okruszek A; Pankiewicz K; Stec WJ; Czownicki Z; Utracka B
    J Med Chem; 1983 May; 26(5):674-9. PubMed ID: 6842506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new chiral shift reagent for the determination of enantiomeric excess and absolute configuration in cyanohydrins.
    Moon LS; Jolly RS; Kasetti Y; Bharatam PV
    Chem Commun (Camb); 2009 Mar; (9):1067-9. PubMed ID: 19225638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H-NMR studies of drugs with chiral solvating agent: the direct enantiomeric purity determination of the chiral anesthetic, prilocaine.
    Hanna GM
    Enantiomer; 2000; 5(3-4):303-12. PubMed ID: 11126871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical purity determination and (1)H NMR spectral simplification with lanthanide shift reagents - V. Mephenytoin, 5-ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione.
    Avolio J; Rothchild R
    J Pharm Biomed Anal; 1984; 2(3-4):403-8. PubMed ID: 16867720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of enantiomeric purity of glycerides with a chiral PMR shift reagent.
    Bus J; Lok CM; Groenewegen A
    Chem Phys Lipids; 1976 Mar; 16(2):123-32. PubMed ID: 1269066
    [No Abstract]   [Full Text] [Related]  

  • 20. 1H NMR spectral simplification with achiral and chiral lanthanide shift reagents--IV. Thiopental and barbiturate analogues.
    Eberhart ST; Hatzis A; Jimenez J; Rothchild R; Simons P
    J Pharm Biomed Anal; 1987; 5(3):233-45. PubMed ID: 16867520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.